Omadacycline Shows Promise as Safe, Effective C Diff Antibio

Participants given omadacycline had high fecal concentrations with a distinct microbiome profile compared to those in the vancomycin group, with study results calling attention to the importance of antibiotics’ impact on the gut microbiome.

Related Keywords

United States , Kevin Garey , Robertl Boblitt , University Of Houston College Pharmacy , Us Centers For Disease , University Of Houston Kevin Garey , University Of Houston , Robertl Boblitt Endowed Professor , Drug Discovery , Houston College , Disease Control , Gut Microbiome Effects , Oral Omadacycline Versus Vancomycin , Healthy Volunteers , Infectious Diseases , C Diff , Clostridioides Difficile , Wvancomycin , Omadacycline , Antibiotic , Recurrence , Microbiome , Microbiota , Fecal Pharmacokinetics ,